Petri Dish Market - Size, Share, and Forecast to 2026

Petri dish also called as cell culture dishes is common glassware used in research and academic laboratories and hospital in order to hold, transfer, and incubate the sample substance under study. Glass petri dish has lid over it and it majorly used to hold the culture medium of Agar on which bacteria, fungus, and virus are grown, which can be studied for various purpose. Petri dish prevents culturing microorganisms while separating them from airborne contaminates.

Petri dish is significant Labware in almost all research efforts, in addition many infectious disease are diagnosed with culture medium method that utilizes petri dish. Majorly glass petri dish are used for various experimental activities. However, polystyrene plastic petri dish are also used according to sample need, as some samples are incompatible or react with glass material.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1978

The global petri dish market size was valued at US$ 155.2 million in 2017, and is expected to witness a CAGR of 3.6% over the forecast period (2018 – 2026).

Petri dish is common lab ware used to grow and experiment over microbiological culture. Furthermore, it is also used in medical diagnostic field to confirm presence of different bacteria and virus in infectious disease. Petri dish is glass based or polystyrene based with lid that prevents contamination of sample from the airborne bacteria and virus. Petri dish comes with different diameters and designs. Standard petri dish is round glass made without any compartment. Two compartment, three compartment are some other variants. Contact plate are used for determining surface microbial contamination. New types petri dish ventilation lugs on underside of lid allow for venting, and prevent condensation from developing and dripping onto culture.

Market Dynamics

Petri dish market is driven by increased research and development efforts across world in science and medical field. Especially considering high prevalence of chronic disease and deaths, which is propelling demand for research and development for improving treatment and diagnosis of these disease. According to the National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from cancer disease. The number of people suffering from cancer is expected to rise to 19 million by 2024, which supports increasing demand for precision medicine. New precision/personalized medicine such as CAR-T cell therapies and monoclonal antibody based drugs can efficiently treat such disease, which is expected to fuel petri dish market growth.

Increasing adoption of precision/personalized medicine and diagnostic techniques to drive petri dish market growth
There is high prevalence of chronic disease such as cancer, cardio vascular disease, and diabetes worldwide, research efforts in developed region has been diverted to personalized medicine to cure this disease. Petri dish market would be supported due to this efforts in finding effective treatment avenues for this disease. Personalized medicine use tools of genomics, proteomics, and cell-based therapies to effectively target disease resulting in greater chance of survival of patient. Petri dish is essential part of most of this process such as cell isolation and cell culture growth.

Well established healthcare infrastructure coupled with high adoption rate of new technology for the treatment of cancer in the developed region is expected to boost overall sales of petri dish in regions such as North America and Europe. There are over 200 companies engaged in development of personalized cell therapy products in the U.S. alone

In 2017, the FDA approved 2 CAR-T cell therapy for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia and adult patients with certain types of large B-cell lymphoma. Such advancement in cell-based therapy needs extensive utilization of petri dish, which is expected to fuel petri dish market growth.

Click To Continue Reading @ https://www.coherentmarketinsights.com/market-insight/petri-dish-market-1978

Key players operating in the petri dish market include Aicor Medical, NEST Biotechnology, Thermo Fisher Scientific, Greiner Bio-One, Corning, Phoenix Biomedical, Millipore Sigma, Reinnervate, Narang Medical Limited, Biosigma S.r.l., Pall Corporation

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.